Treatments & Clinical Trials

Long-term studies show mesenchymal stem cell therapy is safe for Crohn's, sustaining remission for many patients with mainly localized side effects.

Cord blood stem cells reduce inflammation, promote neuron growth, and can improve recovery after traumatic brain injury — research, clinical trials, storage, and uses.

How umbilical cord mesenchymal stem cells repair tendons, ligaments, and cartilage, reduce inflammation, and improve recovery from sports injuries.

Multi-center stem cell trials report regional heart repair and strong safety but mixed long-term efficacy, high costs, and data integrity concerns.

Umbilical cord blood stem cells may reduce amyloid, lower inflammation and support brain repair in Alzheimer’s; early trials show safety and cord blood banking options.

How AI boosts stem cell therapy success for autoimmune diseases by improving predictions, personalization, safety, and continuous monitoring.

Children fare far better than adults after stem cell transplants, but CAR T therapies, haploidentical grafts and cord blood banking are narrowing the gap.

Explains how stem cell therapy can regenerate heart tissue after a heart attack, improve LVEF, reduce heart failure risk, and current delivery challenges.

Banked cord blood and therapies like DUOC-01 show strong trial results—faster availability, lower rejection risk, and improved outcomes for many rare genetic disorders.